Published by Iain Gilbert on 16th September 2019
(Sharecast News) - Biopharmaceutical firm Ovoca Bio narrowed losses slightly in the first half of its trading year, while focus remained firmly on its continued development of a treatment for female sexual dysfunction.
URL: http://www.digitallook.com/dl/news/story/29573883/...